Performance

MPLT -53.36%

Watchlist

Select an item

RETURNS	1D	YTD	1Y	5Y Ann.	Max DD	Sharpe	Div. Yield
MPLT	+5.05%	-58.55%	-53.36%	—	-84.37%	0.11	0.00%

Summary

MPLT at a glance

MPLT returned -53.36% over the past year. Its worst drop in that year was -84.37%, smaller than 1% of stocks on Redstone, and its Sharpe ratio of 0.11 beats 31% of stocks on Redstone. It pays no dividends.

Ranking

How MPLT ranks

Current Drawdown

-81.71%

Rolling Volatility

79.61%

Actions

Metrics

Risk Indicators

Alpha1.75%

Beta1.11x

Sharpe0.11

Sortino0.14

Omega1.02

Calmar-0.63

Martin0.31

Profile

About MPLT

MapLight Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing treatments for central nervous system disorders.

Sector: Health Care
Industry: Pharmaceutical Preparations
Market cap: $405M
Listed: Oct 2025
Employees: 133
Headquarters: Redwood City, CA
Website: maplightrx.com

Comparisons

MPLT: MapLight Therapeutics, Inc.

MPLT at a glance

How MPLT ranks

Current Drawdown

Rolling Volatility

About MPLT

Related comparisons